Heterologous combinatorial biosynthesis of daurichromenic acid derivatives from a common metabolite in Rhododendron species and evaluation of their SARS-CoV-2 inhibitory activities
Phytochemistry · 2026
DOI: 10.1016/j.phytochem.2026.114804 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytochemistry, 2026. Verfasst von Chao Peng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Natural Products Synthetic Biology of Ethnic Medicinal Endophytes, State Ethnic Affairs Commission, Key Laboratory of Chemistry in …. Hauptthemen laut MEDLINE: Rhododendron, Benzopyrans, SARS-CoV-2, Antiviral Agents. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Yunnan Provincial Natural Science Foundation, National Natural Science Foundation of China, Yunnan Provincial Department of Education.
Abstract (Originalsprache)
Rhododendron species, a globally recognized group of medicinal and edible plants, are known to produce a wide array of meroterpenoid natural products. Among these, daurichromenic acid (7) and its derivatives are widely distributed and exhibit diverse biological activities. However, their low natural abundance in plants and the incomplete elucidation of their biosynthetic pathways have hindered further development and application. Capitachromenic acid D (6), a representative chromene compound formed via successive oxidative transformations of 7, was initially isolated from R. capitatum Maxim. and also shows promising biological potential for pharmaceutical applications. In this study, the heterologous combinatorial biosynthesis of compound 6 was achieved in Aspergillus oryzae through the introduction of genes responsible for the biosynthesis of the precursor griffolic acid (2) from Fusarium graminearum 1962, A. oryzae, and Stachybotrys sp. g12, along with a cyclase gene from R. dauricum L. In bioactivity assays, compounds 5 and 6 exhibited notable inhibitory activity against the main protease (Mpro) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with IC50 values of 16.5 ± 1.3 μM and 10.7 ± 1.6 μM, respectively, highlighting their potential as promising lead compounds for SARS-CoV-2 Mpro inhibitor development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Natural Products Synthetic Biology of Ethnic Medicinal Endophytes, State Ethnic Affairs Commission, Key Laboratory of Chemistry in Ethnic Medicinal Resources, Ministry of Education, Yunnan Minzu Univer…
Förderung
- Yunnan Provincial Natural Science Foundation
- National Natural Science Foundation of China
- Yunnan Provincial Department of Education
- Yunnan University
- University of Tokyo
Zitieren
APA
Peng, C., Guo, M. Y., Gao, L., Zhang, X. P., & Wang, W. G. (2026). Heterologous combinatorial biosynthesis of daurichromenic acid derivatives from a common metabolite in Rhododendron species and evaluation of their SARS-CoV-2 inhibitory activities. Phytochemistry. https://doi.org/10.1016/j.phytochem.2026.114804
Vancouver
Peng C, Guo MY, Gao L, Zhang XP, Wang WG. Heterologous combinatorial biosynthesis of daurichromenic acid derivatives from a common metabolite in Rhododendron species and evaluation of their SARS-CoV-2 inhibitory activities. Phytochemistry. 2026. doi:10.1016/j.phytochem.2026.114804
BibTeX
@article{Peng2026,
author = {Peng, Chao and Guo, Meng-Yun and Gao, Lu and Zhang, Xu-Ping and Wang, Wei-Guang},
title = {Heterologous combinatorial biosynthesis of daurichromenic acid derivatives from a common metabolite in Rhododendron species and evaluation of their SARS-CoV-2 inhibitory activities},
journal = {Phytochemistry},
year = {2026},
doi = {10.1016/j.phytochem.2026.114804}
}
EUVIMED